DexCom
DXCM
79.32
-0.87
-1.08%
DexCom
US · DXCM
#635 by market cap
Listed 2005
79.32
-0.87
-1.08%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q4).
- Total institutional ownership fell 0.4 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 101.69% -0.37pp
- Institutions
- 1,313 -3
- As of
- 2026/Q4 vs. prior period
Holder types
Mutual Fund82.16%
Hedge Fund5.89%
Public Company4.65%
Government Pension Fund3.47%
Private Company2.63%
Sovereign Wealth Fund1.99%
VC/PE Fund0.25%
Individual/Insider0.24%
Insurance Company0.23%
Top holders as of 2026-09-30
BlackRock
10.32% · 38.50M sh
Vanguard Capital Management, LLC
7.21% · 26.89M sh
Vanguard Portfolio Management, LLC
5.31% · 19.79M sh
State Street Global Advisors
5.07% · 18.90M sh
Baillie Gifford
3.89% · 14.52M sh
Invesco Capital Management LLC
3.72% · 13.88M sh
UBS Asset Management
3.41% · 12.71M sh
Geode Capital Management, LLC
3.34% · 12.46M sh
AllianceBernstein
3.14% · 11.69M sh
Arrowstreet Capital, Limited Partnership
2.10% · 7.83M sh
Wellington Management Group
2.29% · 8.53M sh
Norges Bank Investment Management
1.84% · 6.87M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 11 buys · 38 sells
| Name | Role | Stake |
|---|---|---|
| Jacob Leach | Chief Executive Officer | 0.09% |
| Kevin Sayer | Executive Chairperson | 0.05% |
| Steven Altman | Independent Director | 0.02% |
| Jereme Sylvain | Executive VP, CFO, COO & Chief Accounting Officer | 0.02% |
| Sadie Stern | Executive VP, Chief People & Culture Officer | 0.01% |
| Mark Foletta | Lead Independent Director | 0.01% |
| Richard Collins | Independent Director | 0.01% |
| Nicholas Augustinos | Independent Director | 0.01% |
| Michael Brown | Executive VP, Chief Legal & Compliance Officer | 0.01% |
| Bridgette Heller | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-07 | Jacob Leach | Chief Executive Officer | Sale to Issuer | -1,451 | $79.41 |
| 2026-11-07 | Jereme Sylvain | Executive VP, CFO, COO & Chief Accounting Officer | Sale to Issuer | -1,451 | $79.41 |
| 2026-11-07 | Sadie Stern | Executive VP, Chief People & Culture Officer | Sale to Issuer | -1,451 | $79.41 |
| 2026-11-07 | Michael Brown | Executive VP, Chief Legal & Compliance Officer | Sale to Issuer | -1,451 | $79.41 |
| 2026-10-29 | Euan Ashley | Independent Director | Other Disposition | -2,389 | -- |
| 2026-10-26 | Sadie Stern | Executive VP, Chief People & Culture Officer | Automatic Disposition | -2,565 | $78.62 |
| 2026-10-26 | Sadie Stern | Executive VP, Chief People & Culture Officer | Intent to Sell (Form 144) | -2,565 | $78.62 |
| 2026-10-14 | Michael Brown | Executive VP, Chief Legal & Compliance Officer | Automatic Disposition | -1,700 | $85.48 |
| 2026-10-14 | Michael Brown | Executive VP, Chief Legal & Compliance Officer | Intent to Sell (Form 144) | -1,700 | $85.48 |
| 2026-09-27 | Sadie Stern | Executive VP, Chief People & Culture Officer | Automatic Disposition | -2,565 | $86.15 |
| 2026-09-14 | Nicholas Augustinos | Independent Director | Automatic Disposition | -8,089 | $84.02–84.04 |
| 2026-09-14 | Nicholas Augustinos | Independent Director | Intent to Sell (Form 144) | -6,539 | $84.04 |
| 2026-09-14 | Michael Brown | Executive VP, Chief Legal & Compliance Officer | Automatic Disposition | -1,700 | $84.04 |
| 2026-09-13 | Nicholas Augustinos | Independent Director | Intent to Sell (Form 144) | -1,550 | $84.02 |
| 2026-09-09 | Glenn Boehnlein | Independent Director | Other Acquisition | +5,841 | -- |
| 2026-09-09 | Glenn Boehnlein | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-09-09 | Jereme Sylvain | Executive VP, CFO, COO & Chief Accounting Officer | Automatic Disposition | -3,638 | $83.27 |
| 2026-08-26 | Sadie Stern | Executive VP, Chief People & Culture Officer | Automatic Disposition | -2,565 | $88.37 |
| 2026-08-21 | Jacob Leach | Chief Executive Officer | Sale to Issuer | -1,451 | $92.34 |
| 2026-08-21 | Jereme Sylvain | Executive VP, CFO, COO & Chief Accounting Officer | Sale to Issuer | -1,451 | $92.34 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:21 · For reference only, not investment advice and not tailored to your situation.
DexCom discussion 0 comments